146 related articles for article (PubMed ID: 18540980)
1. Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone.
Ozdemir S; Ozdemir M; Toy H
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):358-9. PubMed ID: 18540980
[No Abstract] [Full Text] [Related]
2. Drospirenone and PCOS.
Bhathena RK
J Fam Plann Reprod Health Care; 2005 Jan; 31(1):81. PubMed ID: 15720866
[No Abstract] [Full Text] [Related]
3. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
De Leo V; Morgante G; Piomboni P; Musacchio MC; Petraglia F; Cianci A
Fertil Steril; 2007 Jul; 88(1):113-7. PubMed ID: 17418832
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study.
Battaglia C; Mancini F; Fabbri R; Persico N; Busacchi P; Facchinetti F; Venturoli S
Fertil Steril; 2010 Sep; 94(4):1417-1425. PubMed ID: 19591981
[TBL] [Abstract][Full Text] [Related]
5. The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.
Cakiroglu Y; Vural B; Isgoren S
Arch Gynecol Obstet; 2013 Jul; 288(1):213-20. PubMed ID: 23377194
[TBL] [Abstract][Full Text] [Related]
6. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
Somma MA
Am Fam Physician; 2004 May; 69(10):2425-6. PubMed ID: 15168965
[No Abstract] [Full Text] [Related]
7. The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
Sağsöz N; Orbak Z; Noyan V; Yücel A; Uçar B; Yildiz L
Fertil Steril; 2009 Aug; 92(2):660-6. PubMed ID: 18973889
[TBL] [Abstract][Full Text] [Related]
8. Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study.
Sánchez LA; Pérez M; Centeno I; David M; Kahi D; Gutierrez E
Fertil Steril; 2007 Mar; 87(3):712-4. PubMed ID: 17118366
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Krunic A; Ciurea A; Scheman A
J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
[TBL] [Abstract][Full Text] [Related]
11. An Unusual Case of Right Flank Pain.
Varma PP; Varma E; Bajpai G
Am J Kidney Dis; 2021 Jul; 78(1):A12-A14. PubMed ID: 34167670
[No Abstract] [Full Text] [Related]
12. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome.
Al-Inany H
Clin Evid; 2005 Dec; (14):2343-51. PubMed ID: 16620491
[No Abstract] [Full Text] [Related]
14. [Antiandrogen therapy in the polycystic ovary syndrome].
Messina M; Milani P; Gentile L; Gellona A; Monaco A; Manieri C
Minerva Endocrinol; 1987; 12(3):231-8. PubMed ID: 3657744
[No Abstract] [Full Text] [Related]
15. Polycystic ovary syndrome.
Al-Inany H
Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
[No Abstract] [Full Text] [Related]
16. Treatment of hirsutism with combined pill containing drospirenone.
Gregoriou O; Papadias K; Konidaris S; Bakalianou K; Salakos N; Vrachnis N; Creatsas G
Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
[TBL] [Abstract][Full Text] [Related]
17. Hirsutism and problem of its management.
Mitra K; Chaudhuri N; Kundu D; Mondal S; Ghose D
Indian J Dermatol; 1982 Apr; 27(2):45-59. PubMed ID: 7129531
[No Abstract] [Full Text] [Related]
18. A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight.
Endrikat J; Sandri M; Gerlinger C; Rübig A; Schmidt W; Fortier M
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):220-8. PubMed ID: 17763260
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
J Drugs Dermatol; 2009 Sep; 8(9):837-44. PubMed ID: 19746676
[TBL] [Abstract][Full Text] [Related]
20. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Franks S; Layton A; Glasier A
Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
